https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-01 / Int. J. Cancer 2007 Feb;120(3):585-93
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-01 / Int. J. Cancer 2007 Feb;120(3):585-932007-02-01 00:00:002019-02-15 08:38:13Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-19 / Cancer Gene Ther. 2007 Apr;14(4):409-202007-01-19 00:00:002019-02-15 08:48:20Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-15 / Clin. Cancer Res. 2007 Jan;13(2 Pt 1):566-575
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-15 / Clin. Cancer Res. 2007 Jan;13(2 Pt 1):566-5752007-01-15 00:00:002019-02-15 08:59:53Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-15 / Cancer Res. 2007 Jan;67(2):429-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-15 / Cancer Res. 2007 Jan;67(2):429-322007-01-15 00:00:002019-02-15 09:22:11Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-10 / J. Virol. 2007 Mar;81(6):2817-30
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-10 / J. Virol. 2007 Mar;81(6):2817-302007-01-10 00:00:002019-02-15 09:00:16p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-08 / Vet. J. 2008 Jan;175(1):126-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-08 / Vet. J. 2008 Jan;175(1):126-92007-01-08 00:00:002019-02-15 09:19:35Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-03 / Vaccine 2007 Mar;25(14):2610-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-03 / Vaccine 2007 Mar;25(14):2610-92007-01-03 00:00:002007-01-03 00:00:00Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Drugs Aging 2007;24(3):197-221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Drugs Aging 2007;24(3):197-2212007-01-01 00:00:002019-02-15 09:24:11Advances in prostate cancer immunotherapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Thyroid 2007 Jan;17(1):53-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Thyroid 2007 Jan;17(1):53-82007-01-01 00:00:002019-02-15 08:53:25Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-812007-01-01 00:00:002007-01-01 00:00:00Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
